You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DIULO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Diulo, and when can generic versions of Diulo launch?

Diulo is a drug marketed by Gd Searle Llc and is included in one NDA.

The generic ingredient in DIULO is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diulo

A generic version of DIULO was approved as metolazone by SANDOZ on December 19th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIULO?
  • What are the global sales for DIULO?
  • What is Average Wholesale Price for DIULO?
Summary for DIULO
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 87
Patent Applications: 5,042
DailyMed Link:DIULO at DailyMed
Drug patent expirations by year for DIULO

US Patents and Regulatory Information for DIULO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc DIULO metolazone TABLET;ORAL 018535-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc DIULO metolazone TABLET;ORAL 018535-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc DIULO metolazone TABLET;ORAL 018535-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.